Crinetics Pharmaceuticals (CRNX) Other Non-Current Assets (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Other Non-Current Assets came in at $800000.0 in Q1 2026, down 38.46% year-on-year from $1.3 million in Q1 2025, and down 96.42% quarter-over-quarter from $22.3 million in Q4 2025.
Crinetics Pharmaceuticals has reported Other Non-Current Assets for 10 years, with the latest figure at $800000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 38.46% year-over-year to $800000.0; the trailing twelve-month figure through Mar 2026 stood at $800000.0 (down 38.46% YoY), and the FY2025 full-year result was $22.3 million, up 2690.88% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $800000.0, down from $22.3 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $22.3 million in Q4 2025, with the low at $500000.0 in Q1 2022.
- Average Other Non-Current Assets over 5 years is $2.4 million, with a median of $1.3 million recorded in 2022.
- Year-over-year, Other Non-Current Assets slumped 38.46% in 2024 and surged 2690.88% in 2025.
- Tracing CRNX's Other Non-Current Assets over 5 years: stood at $1.3 million in 2022, then fell by 0.08% to $1.3 million in 2023, then slumped by 38.46% to $800000.0 in 2024, then surged by 2690.88% to $22.3 million in 2025, then tumbled by 96.42% to $800000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $800000.0 (Q1 2026), $22.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 22.33 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 12,000.00 |
| Jun 30, 2018 | 2.45 Mn |
| Dec 31, 2017 | 33,000.00 |